Search research articles
Contact Us
Filters
Showing results (91-100 of 241) with videos related to
Page
of 25
Sort By:
Blood
|
June 17, 1998
The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1
R Möhle, F Bautz, S Rafii, et al.
Blood
|
February 1, 1994
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors
W Brugger, K J Bross, M Glatt, et al.
Blood
|
September 1, 1994
Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin
W Brugger, R Henschler, S Heimfeld, et al.
Leukemia & Lymphoma
|
August 15, 2003
Complete remission of third recurrence of acute myeloid leukemia after treatment with imatinib (STI-571)
M Schittenhelm, O Aichele, S M Kröber, et al.
Cancer
|
May 1, 1997
Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation
F C Dimeo, M H Tilmann, H Bertz, et al.
Bone Marrow Transplantation
|
January 7, 1998
High-dose chemotherapy with autologous peripheral blood stem cell transplantation for metastatic gastric leiomyosarcoma
S Fetscher, W Brugger, H Bertz, et al.
Blood
|
March 1, 1992
Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin
W Brugger, K Bross, J Frisch, et al.
Investigational New Drugs
|
August 25, 2000
A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors
J T Hartmann, L M Fels, S Knop, et al.
Der Radiologe
|
September 28, 2000
[The MR characterization of the composition of the hematopoietic bone marrow. The findings in generalized neoplasms and the monitoring of therapy]
J Machann, P L Pereira, H Einsele, et al.
Journal of Hematotherapy & Stem Cell Research
|
January 19, 2002
Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging
R Stilz, F Grünebach, P Bader, et al.
Page
of 25
Search research articles
Search
Showing results (91-100 of 241) with videos related to
Sort By:
Page
of 25
Blood
|
June 17, 1998
The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1
R Möhle, F Bautz, S Rafii, et al.
Blood
|
February 1, 1994
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors
W Brugger, K J Bross, M Glatt, et al.
Blood
|
September 1, 1994
Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin
W Brugger, R Henschler, S Heimfeld, et al.
Leukemia & Lymphoma
|
August 15, 2003
Complete remission of third recurrence of acute myeloid leukemia after treatment with imatinib (STI-571)
M Schittenhelm, O Aichele, S M Kröber, et al.
Cancer
|
May 1, 1997
Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation
F C Dimeo, M H Tilmann, H Bertz, et al.
Bone Marrow Transplantation
|
January 7, 1998
High-dose chemotherapy with autologous peripheral blood stem cell transplantation for metastatic gastric leiomyosarcoma
S Fetscher, W Brugger, H Bertz, et al.
Blood
|
March 1, 1992
Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin
W Brugger, K Bross, J Frisch, et al.
Investigational New Drugs
|
August 25, 2000
A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors
J T Hartmann, L M Fels, S Knop, et al.
Der Radiologe
|
September 28, 2000
[The MR characterization of the composition of the hematopoietic bone marrow. The findings in generalized neoplasms and the monitoring of therapy]
J Machann, P L Pereira, H Einsele, et al.
Journal of Hematotherapy & Stem Cell Research
|
January 19, 2002
Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging
R Stilz, F Grünebach, P Bader, et al.
Page
of 25